Patents by Inventor Edouard Prost

Edouard Prost has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Recombinant proteins having haemostatic activity and capable of inducing platelet aggregation
    Patent number: 9115183
    Abstract: Recombinant proteins capable of inducing platelet aggregation and uses thereof.
    Type: Grant
    Filed: June 7, 2013
    Date of Patent: August 25, 2015
    Assignee: CENTRE HOSPITALIER UNIVERSITAIRE DE DIJON
    Inventors: David Vandroux, Emmanuel De Maistre, Edouard Prost
  • Recombinant proteins having haemostatic activity and capable of inducing platelet aggregation
    Patent number: 8557774
    Abstract: Disclosed herein are recombinant proteins capable of inducing platelet aggregation and uses thereof.
    Type: Grant
    Filed: September 22, 2009
    Date of Patent: October 15, 2013
    Assignee: Centre Hospitalier Universitaire de
    Inventors: David Vandroux, Emmanuel De Maistre, Edouard Prost
  • RECOMBINANT PROTEINS HAVING HAEMOSTATIC ACTIVITY AND CAPABLE OF INDUCING PLATELET AGGREGATION
    Publication number: 20130260456
    Abstract: Recombinant proteins capable of inducing platelet aggregation and uses thereof.
    Type: Application
    Filed: June 7, 2013
    Publication date: October 3, 2013
    Inventors: David Vandroux, Emmanuel De Maistre, Edouard Prost
  • Recombinant adenoviruses, use thereof for preparing AAVS, complementary cell line, and pharmaceutical compositions containing said adenoviruses
    Patent number: 7033826
    Abstract: A recombinant adenovirus in which the expression of a nucleic acid sequence coding for at least one homologous or heterologous gene of viral origin is placed under the control of an inducible promoter, is disclosed. The use of such recombinant adenoviruses for preparing AAVs, and a complementary cell line and preparation method therefor, are also disclosed. Furthermore, pharmaceutical compositions containing such an adenovirus are disclosed.
    Type: Grant
    Filed: April 15, 2002
    Date of Patent: April 25, 2006
    Assignee: Aventis Pharma S.A.
    Inventors: Michel Perricaudet, Martine Latta, Edouard Prost, Patrice Yeh, Cécile Orsini, Emmanuelle Vigne
  • Recombinant adenoviruses, use thereof for preparing AAVS, complementary cell line, and pharmaceutical compositions containing said adenoviruses
    Publication number: 20030039634
    Abstract: A recombinant adenovirus in which the expression of a nucleic acid sequence coding for at least one homologous or heterologous gene of viral origin is placed under the control of an inducible promoter, is disclosed. The use of such recombinant adenoviruses for preparing AAVs, and a complementary cell line and preparation method therefor, are also disclosed. Furthermore, pharmaceutical compositions containing such an adenovirus are disclosed.
    Type: Application
    Filed: April 15, 2002
    Publication date: February 27, 2003
    Inventors: Michel Perricaudet, Martine Latta, Edouard Prost, Patrice Yeh, Cecile Orsini, Emmanuelle Vigne
  • RECOMBINANT ADENOVIRUSES CONTAINING AN INDUCIBLE PROMOTER CONTROLLING A GENE OF VIRAL ORIGIN
    Publication number: 20020098165
    Abstract: A recombinant adenovirus in which the expression of a nucleic acid sequence coding for at least one homologous or heterologous gene of viral origin is placed under the control of an inducible promoter, is disclosed. The use of such recombinant adenoviruses for preparing AAVs, and a complementary cell line and preparation method therefor, are also disclosed. Furthermore, pharmaceutical compositions containing such an adenovirus are disclosed.
    Type: Application
    Filed: December 19, 1997
    Publication date: July 25, 2002
    Applicant: Rhone-Poulenc S.A.
    Inventors: MICHEL PERRICAUDET, MARTINE LATTA, EDOUARD PROST, PATRICE YEH, CECILE ORSINI, EMMANUELLE VIGNE
  • Recombinant adenoviruses containing an inducible promoter controlling a gene of viral origin
    Patent number: 6420170
    Abstract: A recombinant adenovirus in which the expression of a nucleic acid sequence coding for at least one homologous or heterologous gene of viral origin is placed under the control of an inducible promoter, is disclosed. The use of such recombinant adenoviruses for preparing AAVs, and a complementary cell line and preparation method therefor, are also disclosed. Furthermore, pharmaceutical compositions containing such an adenovirus are disclosed.
    Type: Grant
    Filed: December 19, 1997
    Date of Patent: July 16, 2002
    Assignee: Aventis Pharma S.A.
    Inventors: Michel Perricaudet, Martine Latta, Edouard Prost, Patrice Yeh, Cécile Orsini, Emmanuelle Vigne
  • Cells for the production of recombinant adenoviruses
    Patent number: 6127175
    Abstract: The invention relates to cells usable for the production of defective adenoviruses comprising, inserted into their genome, a portion of the region E4 of an adenovirus genome carrying the reading phase ORF6 under the control of a functional promoter.
    Type: Grant
    Filed: July 17, 1997
    Date of Patent: October 3, 2000
    Assignee: Rhone-Poulenc Rorer S.A.
    Inventors: Emmanuelle Vigne, Michel Perricaudet, Jean-Fran.cedilla.ois Dedieu, Cecile Orsini, Patrice Yeh, Martine Latta, Edouard Prost